Login | Register
Profile | Log out
logo

  • Home
  • News
  • Opinion
  • Other
    • Market Updates
    • Explainers
    • Satire
  • About
  • Contact Us
    • Contact
    • Get Covered
    • Posting Guidelines
  • Subscribe
Submit An Article

asx agh

  • Home
  •  
  • asx agh



  • Most Read
  • Latest Comments
  • Althea to make a splash in the US with new cannabis-based sodas
    • News

    RBA and ASIC up the ante on blockchain project, ASX writes off millions
    Public
  • Althea to make a splash in the US with new cannabis-based sodas
    • News

    AV uptake leads Audinate to push European expansion through recruiting drive
    Public
  • Althea to make a splash in the US with new cannabis-based sodas
    • Opinion

    What the SportsBet-BetEasy merger means for TabCorp and punters
    Public
  • Althea to make a splash in the US with new cannabis-based sodas
    • News

    Why this Tasmanian whisky brand had a record sales quarter
    Public
  • Althea to make a splash in the US with new cannabis-based sodas
    Tremors from the FTX collapse continue to be felt as DigitalX sells off 15% Bitcoin holdings
    • Review
    • January 10, 2023
  • Opening a new frontier in treating Parkinson’s disease
    • Review
    • November 11, 2022
  • AUDC stablecoin gathers momentum as Novatti confirms integration with XRP Ledger
    • Review
    • June 9, 2022
  • PharmAust completes dosing first cohort for MND treatment, patients respond positively
    • Review
    • January 6, 2023
  • Is this the most hated company on the ASX?
    • Review
    • August 16, 2019

Latest Articles

  • ECS Botanics secures distribution rights to bring Terphogz’s ‘The Original Z’ cannabis strain to Australia
    ECS Botanics secures distribution rights to bring Terphogz’s ‘The Original Z’ cannabis strain to Australia
    • News

  • Bioxyne leads the way as Australia’s first manufacturer of pharmaceutical cannabis gummies
    Bioxyne leads the way as Australia’s first manufacturer of pharmaceutical cannabis gummies
    • News

  • Melodiol moves to clear debt with $12m asset fire sale
    Melodiol moves to clear debt with $12m asset fire sale
    • News

  • Althea to make a splash in the US with new cannabis-based sodas
    Althea to make a splash in the US with new cannabis-based sodas
    • News

  • Melodiol Global Health reports revenue growth amid wider acceptance of medicinal cannabis products
    Melodiol Global Health reports revenue growth amid wider acceptance of medicinal cannabis products
    • News

  • Althea to make a splash in the US with new cannabis-based sodas
    • News

    Althea to make a splash in the US with new cannabis-based sodas

    First they started brewing cannabis-infused beer, now Althea Group (ASX: AGH) is bringing cans of cannabis-based sodas to the market that will inevitably have certain consumers checking whether they’re tripping.  The move is set to shake up the cannabis-based products market as a recreational product that will make a bold entry into the burgeoning US

    Read More
    Public
  • Althea’s cost-cutting proves effective, enters positive cash flow in Q1 FY24
    • News

    Althea’s cost-cutting proves effective, enters positive cash flow in Q1 FY24

    After witnessing a cash burn of $368k in the previous quarter, Cannabis-based pharmaceutical company Althea Group (ASX: AGH) has entered cash flow positivity from its operating activities in Q1 FY24, resulting in a net cash inflow of $35,000. This achievement can be attributed to the Company’s successful cost-cutting initiatives, which have begun to yield results.

    Read More
    Public
  • Cannabis lemonade and iced teas: Althea’s Peak teams up with Tweed to bring cannabis-infused products to Canada
    • News

    Cannabis lemonade and iced teas: Althea’s Peak teams up with Tweed to bring cannabis-infused products to Canada

    Cannabis is the most widely-used illicit drug worldwide; about 2.5% of the world, i.e. approximately 150 million people, consume cannabis, and Australia is among the top countries leading the trend. While it sounds the alarm on the concerning drug abuse problem, it also signals a profitable market for companies in the field.   Cannabis-based medicine and

    Read More
    Public
  • Althea launches highest-concentration cannabis medication
    • News

    Althea launches highest-concentration cannabis medication

    Growing in areas that matter, cannabis medication producer Althea Group (ASX: AGH) has been increasing its global distribution offerings with the launch of its latest products; the Althea CBD25 soft gel capsules and the THC25 dried flower. Product development is the cornerstone of market share leadership in an industry still in its infancy. With the

    Read More
    Public
  • Althea Group delivering record year following expansion into global markets
    • News

    Althea Group delivering record year following expansion into global markets

    The cheers of the cannabis industry can be heard loud and clear as the demand for the plant continues to prop up their profits. The last few years have been huge for the industry as companies attempt to strengthen earnings by out-scaling competitors.  One company hoping to come out on top is Althea Group (ASX:

    Read More
    Public
  • Free weed for the leprechauns as Althea Group enters Ireland
    • News

    Free weed for the leprechauns as Althea Group enters Ireland

    The burgeoning arms of cannabis treatment have made their way to Ireland, with regulators easing restrictions which has increased the amount of qualified retailers.  Currently, there is a limited number of cannabis retailers in the Republic of Ireland. Today, Althea Group Holdings (ASX: AGH) has been granted a rare opportunity to enter the Irish cannabis

    Read More
    Public
  • 1
  • 2

Login or register for free to access unlimited reading

Register Now!
  • News

  • Opinion

  • Satire

  • About

  • Contact Us

  • Subscribe

The content published on this website is solely for general information purposes and is not to be construed as financial advice. Should you seek financial advice you should consult with an appropriately qualified person. Opinions expressed on this site are subject to change without notice and The Sentiment who produced this content is under no obligation to keep the information current. The Sentiment, affiliated companies & associates may have a conflict of interest with companies discussed on the website due to commercial arrangements, for example they may be shareholders in the company, be engaged by them to assist in investor communications or receive commission/brokerage for funds raised.

Copyright © 2020 The Sentiment. All rights reserved.
Subscribe

Enter your email address below to subscribe to The Sentiment’s weekly newsletter, highlighting the top news, research, opinion and satire articles shaping ASX investor sentiment.

The Sentiment respects your privacy and will not spam you. View our privacy policy here.